{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:51:23Z","timestamp":1784735483313,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272056"],"award-info":[{"award-number":["82272056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Harbin Medical University Research Project","award":["SYDW2025-003"],"award-info":[{"award-number":["SYDW2025-003"]}]},{"name":"Joint Fund of Zhejiang Provincial Natural Science Foundation of China","award":["ZCLKLZ25H1602"],"award-info":[{"award-number":["ZCLKLZ25H1602"]}]},{"name":"The Ningbo Major Research and Development Plan Project","award":["2024Z214"],"award-info":[{"award-number":["2024Z214"]}]},{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2024J043"],"award-info":[{"award-number":["2024J043"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ningbo Yongjiang Talent Programme","award":["2023"],"award-info":[{"award-number":["2023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01432-w","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T16:14:22Z","timestamp":1776615262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and evaluation of the first-in-class nanobody based PET tracer targeting human inducible T-cell co-stimulator receptor"],"prefix":"10.1186","volume":"16","author":[{"given":"Jianming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunyu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"issue":"11","key":"1432_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1432_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.140","volume":"3","author":"A Medina","year":"2024","unstructured":"Medina A, Carballo J, Gonz\u00e1lez-Marcano E, Blanca I, Convit AF. Breast cancer immunotherapy: realities and advances. Cancer Innov. 2024;3(5):e140.","journal-title":"Cancer Innov"},{"key":"1432_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2017.10.017","volume":"88","author":"M Tazdait","year":"2018","unstructured":"Tazdait M, Mezquita L, Lahmar J, Ferrara R, Bidault F, Ammari S, et al. Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: comparison of RECIST 1.1, irRECIST and iRECIST criteria. Eur J Cancer. 2018;88:38\u201347.","journal-title":"Eur J Cancer"},{"issue":"5","key":"1432_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/cai2.53","volume":"2","author":"S Ali Mohammad","year":"2023","unstructured":"Ali Mohammad S, Hak A, Pogu SV, Rengan AK. Radiotherapy, photodynamic therapy, and cryoablation-induced abscopal effect: challenges and future prospects. Cancer Innov. 2023;2(5):323\u201345.","journal-title":"Cancer Innov"},{"issue":"2","key":"1432_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/cai2.65","volume":"2","author":"F Guo","year":"2023","unstructured":"Guo F, Li C, Liu S, Li Z, Zhai J, Wang Z, Xu B. High BRCA1 expression is an independent prognostic biomarker in LUAD and correlates with immune infiltration. Cancer Innov. 2023;2(2):91\u20135.","journal-title":"Cancer Innov"},{"issue":"6","key":"1432_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/cai2.100","volume":"2","author":"J Shao","year":"2023","unstructured":"Shao J, Liu C, Wang J. Advances in research on molecular markers in immune checkpoint inhibitor-associated myocarditis. Cancer Innov. 2023;2(6):439\u201347.","journal-title":"Cancer Innov"},{"issue":"4","key":"1432_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.70018","volume":"4","author":"Y Gong","year":"2025","unstructured":"Gong Y, Lin W, Fang X, Zhang R, Luo M, Wu H, et al. Advances in cellular immune theranostic approaches for glioblastoma: current trends and future directions. Cancer Innov. 2025;4(4):e70018.","journal-title":"Cancer Innov"},{"key":"1432_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102040","author":"A Amgheib","year":"2022","unstructured":"Amgheib A, Fu R, Aboagye EO. Positron emission tomography probes for imaging cytotoxic immune cells. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14102040.","journal-title":"Pharmaceutics"},{"issue":"6","key":"1432_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2967\/jnumed.124.268289","volume":"66","author":"AS Parihar","year":"2025","unstructured":"Parihar AS, Pant N, Heidari P, Fong L, Iravani A. Approaches to imaging immune activation using PET. J nuclear medicine: official publication Soc Nuclear Med. 2025;66(6):839\u201347.","journal-title":"J nuclear medicine: official publication Soc Nuclear Med"},{"issue":"2","key":"1432_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2214\/AJR.16.16532","volume":"208","author":"S Sheikhbahaei","year":"2017","unstructured":"Sheikhbahaei S, Mena E, Yanamadala A, Reddy S, Solnes LB, Wachsmann J, et al. The value of FDG PET\/CT in treatment response assessment, follow-up, and surveillance of lung cancer. AJR Am J Roentgenol. 2017;208(2):420\u201333.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"1432_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.121","volume":"3","author":"X Chen","year":"2024","unstructured":"Chen X, Shou J, Li S, Fan Y, Zhang J. (18)F-FDG PET\/CT findings of paratesticular alveolar rhabdomyosarcoma. Cancer Innov. 2024;3(2):e121.","journal-title":"Cancer Innov"},{"issue":"12","key":"1432_CR12","first-page":"1908","volume":"66","author":"U Akca","year":"2025","unstructured":"Akca U, Zhang Y, Yasui N, Hensley C, Sorace A, Larimer BM, et al. PET imaging of system A amino acid transport detects early response to immune checkpoint inhibitor therapy in a syngeneic mouse model. J nuclear medicine: official publication Soc Nuclear Med. 2025;66(12):1908\u201313.","journal-title":"J nuclear medicine: official publication Soc Nuclear Med"},{"issue":"13","key":"1432_CR13","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1158\/0008-5472.CAN-19-0267","volume":"79","author":"J Levi","year":"2019","unstructured":"Levi J, Lam T, Goth SR, Yaghoubi S, Bates J, Ren G, et al. Imaging of activated T cells as an early predictor of immune response to anti-PD-1 therapy. Cancer Res. 2019;79(13):3455\u201365.","journal-title":"Cancer Res"},{"issue":"25","key":"1432_CR14","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.7150\/thno.37924","volume":"9","author":"M Krekorian","year":"2019","unstructured":"Krekorian M, Fruhwirth GO, Srinivas M, Figdor CG, Heskamp S, Witney TH, Aarntzen E. Imaging of T-cells and their responses during anti-cancer immunotherapy. Theranostics. 2019;9(25):7924\u201347.","journal-title":"Theranostics"},{"issue":"20","key":"1432_CR15","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1158\/1078-0432.CCR-18-0261","volume":"24","author":"JW Seo","year":"2018","unstructured":"Seo JW, Tavar\u00e9 R, Mahakian LM, Silvestrini MT, Tam S, Ingham ES, et al. CD8(+) T-cell density imaging with (64)Cu-labeled Cys-Diabody informs immunotherapy protocols. Clin Cancer Res. 2018;24(20):4976\u201387.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1432_CR16","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-18-2407","volume":"25","author":"BM Larimer","year":"2019","unstructured":"Larimer BM, Bloch E, Nesti S, Austin EE, Wehrenberg-Klee E, Boland G, et al. The effectiveness of checkpoint inhibitor combinations and administration timing can be measured by Granzyme B PET imaging. Clin Cancer Res. 2019;25(4):1196\u2013205.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1432_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nri1131","volume":"3","author":"CE Rudd","year":"2003","unstructured":"Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat Rev Immunol. 2003;3(7):544\u201356.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"1432_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1158\/2326-6066.CIR-13-0155","volume":"2","author":"H Chen","year":"2014","unstructured":"Chen H, Fu T, Suh WK, Tsavachidou D, Wen S, Gao J, Ng Tang D, He Q, Sun J, Sharma P. CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy. Cancer Immunol Res. 2014;2(2):167\u201376.","journal-title":"Cancer Immunol Res"},{"issue":"14","key":"1432_CR19","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1158\/0008-5472.CAN-19-3265","volume":"80","author":"Z Xiao","year":"2020","unstructured":"Xiao Z, Mayer AT, Nobashi TW, Gambhir SS. ICOS is an indicator of T-cell-mediated response to cancer immunotherapy. Cancer Res. 2020;80(14):3023\u201332.","journal-title":"Cancer Res"},{"issue":"6","key":"1432_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.153","volume":"3","author":"Q Liu","year":"2024","unstructured":"Liu Q, Liu Y, Yang Z. Leukocyte immunoglobulin-like receptor B4: a keystone in immune modulation and therapeutic target in cancer and beyond. Cancer Innov. 2024;3(6):e153.","journal-title":"Cancer Innov"},{"issue":"3","key":"1432_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.112","volume":"3","author":"S Seth","year":"2024","unstructured":"Seth S, Chen R, Liu Y, Fujimoto J, Hong L, Reuben A, et al. Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes. Cancer Innov. 2024;3(3):e112.","journal-title":"Cancer Innov"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01432-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T22:37:23Z","timestamp":1780267043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01432-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01432-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8725887\/v1","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All research involving animal subjects was approved by the Local Ethical Committee of Harbin Medical University Animal Care and Use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}